Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARRY-502 in adults with persistent asthma
NCT01561690Phase 2Completed
- Sponsor
- Pfizer
- Start
- Apr 2012
- Primary completion
- May 2013
- Countries
- 1
01
Overview
A Phase 2 trial of ARRY-502 in asthma, sponsored by Pfizer. Started Apr 2012; status: completed.
02
Drugs
ARRY-502
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01561690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01561690.